Effect of Intratympanic Dexamethasone on Bell’s palsy: A Clinical Trial

Document Type : Original

Authors

1 New Hearing Technologies Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.

2 Otorhinolaryngology Research Center, Tehran University of Medical Sciences, Tehran, Iran.

3 Emergency Medicine and paramedical Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran.

4 School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran.

Abstract

Introduction:
The main objective of this study is to examine the hypothesis that intratympanic corticosteroids can benefit the treatment of Bell's palsy and shorten the period needed for recovery.
Materials and Methods:
This study was conducted prospectively using double-blind clinical trials. A total of 321 patients with acute unilateral facial paralysis were included in the survey, with 144 patients excluded due to exclusion criteria and 177 patients included. These patients were divided into an intervention group (54 patients) and a control group (123 patients). Prednisolone and acyclovir were given orally to both groups. Intratympanic dexamethasone was given to the intervention group as an additional treatment.
Results:
Patients' House-Brackmann (H.B.) scores were recorded when they were visited three days, one week, three weeks, three months, and six months after receiving intratympanic dexamethasone. It was discovered that there was no significant difference in H.B. scores between the intervention and control groups. The first day of symptom improvement in the intervention group was 1.81 days after starting treatment, while it took 2.91 days in the control group, which is a significant difference.
Conclusion:
Intratympanic dexamethasone injection, in addition to the 10-day prednisolone-acyclovir therapy regimen, did not affect patients recovering from Bell's palsy in the short term (three weeks) or long term (six months) but is significantly effective in the first day of recovery as measured by the House-Brackmann scale.

Keywords

Main Subjects

References

  1. Grzybowski A, Kaufman MH. Sir Charles Bell (1774-1842): contributions to neuro-ophthalmology. Acta Ophthalmol Scand. 2007; 85(8): 897-901.
  2. McCormick DP. Herpes-simplex virus as a cause of Bell's palsy. 1972;1(7757):937-939.
  3. Adour KK, Bell DN, Hilsinger RL, Jr. Herpes simplex virus in idiopathic facial paralysis (Bell palsy). 1975;233(6):527-530.
  4. Abramsky O, Webb C, Teitelbaum D, Arnon R. Cellular immune response to peripheral nerve basic protein in idiopathic facial paralysis (Bell's palsy). J Neurol Sci. 1975;26(1):13-20.
  5. McGovern FH, Estevez J, Jackson R. Immunological concept for Bell's palsy: further experimental study. Ann Otol Rhinol Laryngol. 1977;86(3 Pt 1):300-305.
  6. Murakami S, Mizobuchi M, Nakashiro Y, Doi T, Hato N, Yanagihara N. Bell palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle. Ann Intern Med. 1996;124(1 Pt 1):27-30.
  7. Axelsson S, Berg T, Jonsson L, Engström M, Kanerva M, Stjernquist-Desatnik A. Bell's palsy - the effect of prednisolone and/or valaciclovir versus placebo in relation to baseline severity in a randomised controlled trial. Clin Otolaryngol. 2012;37(4):283-290.
  8. Tiemstra JD, Khatkhate N. Bell's palsy: diagnosis and management. Am Fam Physician. 2007;76(7):997-1002.
  9. Gantz B, Rubinstein J, Gidley P, Woodworth G. Surgical Management of Bell??s Palsy. Otology & Neurotology - OTOL NEUROTOL. 2002;23.
  10. Chen N, Zhou M, He L, Zhou D, Li N. Acupuncture for Bell's palsy. Cochrane Database Syst Rev. 2010;2010(8):Cd002914.
  11. Chung JH, Park CW, Lee SH, et al. Intratympanic steroid injection for Bell's palsy: preliminary randomized controlled study. Otol Neurotol. 2014;35(9):1673-1678.
  12. Bryant FL. Intratympanic injection of steroid for treatment of facial paralysis. 1973;83(5):700-706.
  13. Baxter A. Dehiscence of the Fallopian canal. An anatomical study. J Laryngol Otol. 1971;85(6):587-594.
  14. Takahashi H, Sando I. Facial canal dehiscence: histologic study and computer reconstruction. Ann Otol Rhinol Laryngol. 1992;101(11):925-930.
  15. Moreano EH, Paparella MM, Zelterman D, Goycoolea MV. Prevalence of facial canal dehiscence and of persistent stapedial artery in the human middle ear: a report of 1000 temporal bones. 1994;104(3 Pt 1):309-320.
  16. House JW, Brackmann DE. Facial nerve grading system. Otolaryngol Head Neck Surg. 1985; 93(2): 146-147.
  17. Gagyor I, Madhok VB, Daly F, et al. Antiviral treatment for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev. 2015(11): Cd001869.
  18. Hato N, Yamada H, Kohno H, et al. Valacyclovir and prednisolone treatment for Bell's palsy: a multicenter, randomized, placebo-controlled study. Otol Neurotol. 2007;28(3):408-413.
  19. Sullivan FM, Swan IRC, Donnan PT, et al. Early Treatment with Prednisolone or Acyclovir in Bell's Palsy. New England Journal of Medicine. 2007;357(16):1598-1607.
  20. Engström M, Berg T, Stjernquist-Desatnik A, et al. Prednisolone and valaciclovir in Bell's palsy: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet Neurol. 2008;7(11):993-1000.
  21. Yeo SG, Lee YC, Park DC, Cha CI. Acyclovir plus steroid vs steroid alone in the treatment of Bell's palsy. Am J Otolaryngol. 2008;29(3):163-166.
  22. Salinas RA, Alvarez G, Daly F, Ferreira J. Corticosteroids for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev. 2010(3):Cd001942.
  23. Axelsson S, Berg T, Jonsson L, et al. Prednisolone in Bell's palsy related to treatment start and age. Otol Neurotol. 2011;32(1):141-146.
  24. Demir E, Celiker M, Terzi S, et al. EFFICACY OF INTRATYMPANIC STEROID INJECTION IN BELL'S PALSY. 2019.
  25. Inagaki A, Minakata T, Katsumi S, Murakami S. Concurrent Treatment With Intratympanic Dexamethasone for Moderate-Severe Through Severe Bell's Palsy. Otol Neurotol. 2019; 40(10): e1018-e1023.
  26. Allen D, Dunn L. Aciclovir or valaciclovir for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev. 2004(3):Cd001869.
Iranian Journal of Otorhinolaryngology
Volume 36, Issue 6
November and December 2024
Pages 631-637

Files

Share

How to cite

Statistics